BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Amniocentesis
,
Aspirin
,
rs3825942
,
PRKCA
,
G-protein-coupled receptor binding
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
isoniazid
Summary
General Info
Curated Studies
Most Correlated Studies
Broad Connectivity Map (CMAP 2.0) compound database
Liver Pharmacology and Xenobiotic Response Repertoire
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
Hepatocytes from male wistar rats treated with 14 hepatotoxicants
Explore Curated Studies Results
Literature
Most Relevant Literature
Determination of ionization constant and drug-likeness prediction of synthetic isoniazid derivatives…
Rational tuning of binding properties of pillar [5] arene-based sensing material by synergistic effe…
Green synthesis of CQDs for determination of iron and isoniazid in pharmaceutical formulations.
A near-infrared fluorescent probe for detecting hydrazine metabolized from isoniazid in living cells…
Efficacy, safety, and tolerability of isoniazid preventive therapy for tuberculosis in people living…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Pharmacogenetics-guided Isoniazid Dosing in TB-HIV
Pharmacokinetics of Efavirenz in the Presence of Rifampicin and Isoniazid
TBTC Study 28: Moxifloxacin Versus Isoniazid for TB Treatment
Treatment of Latent Tuberculosis Infection With Isoniazid
Point-of-care Pharmacogenomic Testing to Optimize Isoniazid Dosing for Tuberculosis Prevention
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ